Document:

Exhibit
10.1

 

NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A
LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO BORROWER.

 

Issuance
Date: February 29, 2016

Principal
Amount: $400,000

 

8%
CONVERTIBLE NOTE

DUE
February 28, 2017

 

FOR
VALUE RECEIVED, the undersigned, Theranostics Health, Inc., a Delaware corporation (the “Borrower”),
promises to pay to Amarantus Bioscience Holdings, Inc. or its assigns (the “Holder”), or shall have
paid pursuant to the terms hereunder, the principal sum of Four Hundred Thousand Dollars ($400,000) on February 28,
2017 (the “Maturity Date”) or such earlier date as this Note is required or permitted to be repaid as provided
hereunder, and to pay interest, if any, to the Holder on the aggregate unconverted and then outstanding principal amount of this
Note in accordance with the provisions hereof.

 

This
Note is subject to the following additional provisions:

 

Section
1. Definitions. For the purposes hereof, in addition to
the terms defined elsewhere in this Note, the following terms shall have the following meanings:

 

“Bankruptcy
Event” means any of the following events: (a) Borrower or any Subsidiary thereof commences a case or other proceeding
under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation
or similar law of any jurisdiction relating to Borrower or any Subsidiary thereof, (b) there is commenced against Borrower or
any Subsidiary thereof any such case or proceeding that is not dismissed within 60 days after commencement, (c) Borrower or any
Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding
is entered, (d) Borrower or any Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial
part of its property that is not discharged or stayed within 60 calendar days after such appointment, or (e) Borrower or any Subsidiary
thereof makes a general assignment for the benefit of creditors.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action
to close.

 

“Change
of Control Event”  means: except for the acquisition of substantially all the assets of Borrower by Avant
Diagnostics, Inc., (i) any acquisition of Borrower by means of merger, securities purchase or other form of reorganization in
which Borrower's outstanding equity interests are exchanged for securities or other consideration issued, or caused to be issued,
by the acquiring person or any one or more of its subsidiaries or affiliates, unless Borrower's security holders immediately prior
to such merger, securities purchase or reorganization hold more than 50% of the voting power of the surviving or acquiring person
immediately after such merger, securities purchase or reorganization in the same relative proportions, or (ii) the sale of all
or substantially all of the assets of Borrower.

 

    1

     

    

 

“Common
Stock” means the voting common stock of the Borrower.

 

“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Stock

 

“Conversion”
shall have the meaning ascribed to such term in Section 4.

 

“Conversion
Date” shall have the meaning set forth in Section 4.

 

“Conversion
Price” means $40.64 which Conversion Price shall be adjusted as provided in Section 5.

 

“Conversion
Shares” means, collectively, the shares of Common Stock issuable upon conversion of this Note in accordance with the
terms hereof.

 

“Event
of Default” shall have the meaning set forth in Section 7(a).

 

“New
York Courts” shall have the meaning set forth in Section 11(d).

 

“Notice
of Conversion” shall have the meaning set forth in Section 4(a).

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

  

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange, the OTCQB, or the OTCQX (or any successors to any of the foregoing).

 

Section
2. Interest.

 

a)Interest.
The Holder shall be entitled to receive, and Borrower shall pay, simple interest on the outstanding principal amount of this Note
at the annual rate of eight (8%) percent per annum payable in cash on the Maturity Date.

 

b)Payment
Grace Period. The Borrower shall have a ten Business Day grace period to pay any monetary amounts due under this Note except
as specifically set forth herein.

 

c)Calculations.
Interest shall be calculated on the basis of a 365-day year, and shall accrue daily commencing on the date hereof until payment
in full of the outstanding principal, together with all accrued and unpaid interest and other amounts which may become due hereunder,
has been made.

 

    2

     

    

 

d)Manner
and Place of Payment. Principal and interest on this Note and other payments in connection with this Note shall be payable
at the Borrower’s offices as designated above in lawful money of the United States of America in immediately available funds
without set-off, deduction or counterclaim. Upon assignment of the interest of Holder in this Note, Borrower shall instead make
its payment pursuant to the assignee’s instructions upon receipt of written notice thereof.

 

Section
3. Investment Representations. This Note has been
issued subject to certain investment representations of the original Holder set forth in the Investor Representations annexed
hereto as Exhibit A and may be transferred or exchanged only in compliance with the terms contained herein and applicable
federal and state securities laws and regulations to a successor Holder who provides the same investment representations to the
Borrower.

 

Section
4. Conversion.

 

a)
Voluntary Conversion.

 

i.
At Holder’s Option. This Note shall be convertible at any time, in whole and not in part, into the Conversion Shares
at the option of the Holder. The Holder shall effect conversion by delivering to Borrower written notice of Conversion (the “Notice
of Conversion”) which Notice of Conversion shall be accompanied by this Note. The Conversion Date shall be the date
that such Notice of Conversion and this Note is deemed delivered hereunder.

 

ii.
At Holder’s Option. At the option of the Holder at any time after March 31, 2016 if on such date Borrower is not
then subject to a legally binding obligation to sell substantially all of its assets to Avant Diagnostics, Inc., this Note shall
be convertible, in whole and not in part, into the Conversion Shares based on the then applicable Conversion Price. The Borrower
shall effect conversion by delivering to Holder written a Notice of Conversion which Notice of Conversion. Upon delivery of this
shall this Note to Borrower, Borrower shall issue to the Holder the Conversion Shares. The Conversion Date shall be the date that
such Notice of Conversion is deemed delivered hereunder

 

b)
Mandatory Conversion. This Note shall automatically convert into the Conversion Shares on the earliest of the date
upon the occurrence of a Change of Control Event.

 

c)
Mechanics of Conversion.

 

i. Conversion Shares Issuable Upon Conversion. The number of Conversion Shares issuable upon a conversion hereunder
shall be determined by the quotient obtained by dividing (x) the outstanding principal amount of this Note and accrued but unpaid
interest thereon to be converted by (y) the Conversion Price.

 

ii. Delivery
of Certificate Upon Conversion. Not later than five Trading Days after the Conversion Date (the “Share Delivery Date”),
Borrower shall deliver, or cause to be delivered, to the Holder a certificate or certificates representing the Conversion Shares.

 

    3

     

    

 

iii. Reservation
of Shares Issuable Upon Conversion. Borrower covenants that it will at all times reserve and keep available out of its authorized
and unissued shares of Common Stock for the sole purpose of issuance upon conversion of this Note as herein provided, free from
preemptive rights or any other actual contingent purchase rights of Persons other than the Holder, not less than one hundred (100%)
percent of the aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments and restrictions
of Section 5) upon the conversion of the then outstanding principal amount plus accrued interest of this Note at the Conversion
Price (as adjusted from time to time). Borrower covenants that all shares of Common Stock that shall be so issuable shall, upon
issue, be duly authorized, validly issued, fully paid and nonassessable.

 

iv. Fractional
Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this Note. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, Borrower shall at its
election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Conversion Price or round up to the next whole share.

 

v.  Transfer
Taxes and Expenses. The issuance of certificates for shares of the Common Stock on conversion of this Note shall be made without
charge to the Holder hereof for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery
of such certificates, provided that, Borrower shall not be required to pay any tax that may be payable in respect of any transfer
involved in the issuance and delivery of any such certificate upon conversion in a name other than that of the original Holder
of this Note and Borrower shall not be required to issue or deliver such certificates to such other person unless or until such
other person shall have paid to Borrower the amount of such tax or shall have established to the satisfaction of Borrower that
such tax has been paid.

 

Section
5.  Certain Adjustments.

 

a)Stock
Dividends and Stock Splits. If Borrower, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock o, (ii) subdivides outstanding
shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding
shares of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification of shares of the Common
Stock, any shares of capital stock of Borrower, then the Conversion Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding any treasury shares of Borrower) outstanding immediately before such
event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any
adjustment made pursuant to this Section shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case
of a subdivision, combination or re-classification.

 

    4

     

    

 

b)
Subsequent Equity Sales. If the Borrower or any Subsidiary thereof, as applicable, at any time while this Note is outstanding,
shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce
any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents other than
pursuant to an Exempt Issuance (as defined below), at an effective price per share less than the Conversion Price then in effect
(such lower price, the “Base Share Price” and such issuances (excluding any an Exempt Issuance),collectively,
a “Dilutive Issuance”) (it being understood and agreed that if the holder of the Common Stock or Common Stock
Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion,
exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with
such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Conversion
Price, such issuance shall be deemed to have occurred for less than the Conversion Price on such date of the Dilutive Issuance
at such effective price), then simultaneously with the consummation of each Dilutive Issuance the Conversion Price shall be reduced
and only reduced as set forth below and the number of Conversion Shares issuable hereunder shall be increased such that the aggregate
Conversion Price payable hereunder, after taking into account the decrease in the Conversion Price, shall be equal to the aggregate
Conversion Price prior to such adjustment.

 

(i)
If the Dilutive Issuance, together with all other Dilutive Issuances, is for consideration of less than One Million Dollars ($1,000,000),
the Conversion Price shall be adjusted to the product of (w) the sum of Six Million Dollars ($6,000,000) plus the consideration
received by the Borrower with respect to such Dilutive Issuances of Common Stock and that would be received by the Borrower upon
the exercise of any Common Stock Equivalents divided (x) by the number of shares of Common Stock outstanding after the
issuance of shares of Common Stock pursuant to a Dilutive Issuance and that would be outstanding upon the exercise of Common Stock
Equivalents that constitute a Dilutive Issuance.

 

(ii)
If the Dilutive Issuance, together with all other Dilutive Issuances, is for consideration of One Million Dollars ($1,000,000)
or more, the Conversion Price shall be adjusted to equal the Base Share Price.      

 

(iii)
If the Dilutive Issuance is Common Stock that is issued to a creditor of the Borrower or any Subsidiary who has claims against
the Borrower or any Subsidiary as of the date hereof in full or partial satisfaction of the claims of such creditor, the Base
Share Price shall be the value of such shares of Common Stock as agreed upon by the Borrower or any Subsidiary and such creditor
and the consideration received by the Borrower with respect to such Dilutive Issuance shall be (y) the number of shares of Common
Stock so issued multiplied by (z) such agreed upon Base Share Price.

 

b)The
Borrower shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any Common
Stock or Common Stock Equivalents subject to this Section 5(b), indicating therein the applicable issuance price, or applicable
reset price, exchange price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”).
For purposes of clarification, whether or not the Borrower provides a Dilutive Issuance Notice pursuant to this Section 5(b),
upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Conversion Shares based upon the Conversion
Price as adjusted pursuant to this Section 5(b) regardless of whether the Holder accurately refers to the Conversion Price as
adjusted pursuant to this Section 5(b) in the Notice of Conversion. Notwithstanding the foregoing, no adjustments shall be made
to the Conversion Price or the number of Conversion Shares to be issued under this Section 5(b) in respect of an Exempt Issuance.
“Exempt Issuance” means the issuance of (a) shares of Common Stock or options to employees, officers or directors
of the Borrower pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members
of the Board of Directors of the Borrower or a majority of the members of a committee of non-employee directors of the Borrower
established for such purpose, (b) securities upon the exercise or exchange of or conversion of any Notes issued hereunder and/or
other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date
of this Note, provided that such securities have not been amended since the date of this Note to increase the number of such securities
or to decrease the Conversion Price, exchange price or conversion price of such securities, and (c) securities issued pursuant
to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Borrower, provided that
any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries,
an operating entity or an owner of an asset in a business synergistic with the business of the Borrower and shall provide to the
Borrower additional benefits in addition to the investment of funds, but shall not include a transaction in which the Borrower
is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.

 

    5

     

    

 

c)Calculations.
All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section 5, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding any treasury shares of Borrower) issued and outstanding.

 

d)Notice
to the Holder. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 5, Borrower shall promptly
deliver to the Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of
the facts requiring such adjustment.

 

Section
6.Prepayment. The Borrower shall have the option of paying the principal sum of this Note to Holder in advance
in full or in part at any time and from time to time without premium or penalty; provided, however, that together with such payment
in full the Borrower shall pay to the Holder all interest and all other amounts owing pursuant to this Note and remaining unpaid.

 

Section
7. Events of Default.

 

a)
“Event of Default” means, wherever used herein, any
of the following events (whatever the reason for such event and whether such event shall be voluntary or involuntary or effected
by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative
or governmental body):

 

i.any
default in the payment of the principal amount or interest and other amounts owing under this Note, as and when the same shall
become due and payable (whether by acceleration or otherwise) which default is not cured within ten (10) Trading Days; or

 

    6

     

    

 

ii.the
Borrower or any Significant Subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X) shall be subject to a Bankruptcy
Event.

 

b)
Remedies Upon Event of Default. If any Event of Default occurs, the
outstanding principal amount of this Note, interests and other amounts owing in respect thereof through the date of acceleration,
shall become, at the Holder’s election, immediately due and payable in cash. Commencing on the Maturity Date and also five
(5) days after the occurrence of any Event of Default interest on this Note shall accrue at an interest rate of 10%. Upon the
payment in full, the Holder shall promptly surrender this Note to or as directed by Borrower. In connection with such acceleration
described herein, the Holder need not provide, and Borrower hereby waives, any presentment, demand, protest or other notice of
any kind, and the Holder may immediately and without expiration of any grace period enforce any and all of its rights and remedies
hereunder and all other remedies available to it under applicable law. Such acceleration may be rescinded and annulled by Holder
at any time prior to payment hereunder and the Holder shall have all rights as a holder of the Note until such time, if any, as
the Holder receives full payment pursuant to this Section 7(b). No such rescission or annulment shall affect any subsequent Event
of Default or impair any right consequent thereon.

 

Section
8.Borrower’s Representations. The Borrower is duly organized, validly existing and in good standing under
the laws of the jurisdiction of its organization with full power and authority to own, lease, license and use its properties and
assets and to carry out the business in which it proposes to engage. The Borrower has the requisite corporate power and authority
to execute, deliver and perform its obligations under this Note and to issue this Note. All necessary proceedings of the Borrower
have been duly taken to authorize the execution, delivery, and performance of this Note. When this Note is executed and delivered
by the Borrower, it will constitute the legal, valid and binding obligation of the Borrower enforceable against the Borrower in
accordance with their terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement
of applicable creditors' rights and remedies.

 

Section
9.Miscellaneous.

 

a)
Notices. All notices, demands, requests, consents, approvals, and
other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i)
personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered
by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, facsimile or email, addressed
as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or
other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery, delivery by
email or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or
number designated below (if delivered on a business day during normal business hours where such notice is to be received), or
the first business day following such delivery (if delivered other than on a business day during normal business hours where such
notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid,
addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications
shall be: (i) if to Borrower, to: Theranostics Health, Inc., Attn: Kevin Quinn, member of the Board of Directors, ____________,
__________ MD _____, Facsimile (___) ___-____, email: kquinn@wyeriver.com, and (ii) if to the Holder, as indicated in Exhibit
A.

 

    7

     

    

 

b)
Absolute Obligation. Except as expressly provided herein, no provision
of this Note shall alter or impair the obligation of Borrower, which is absolute and unconditional, to pay the principal of, liquidated
damages and accrued interest, as applicable, on this Note at the time, place, and rate, and in the coin or currency, herein prescribed.
This Note is a direct debt obligation of Borrower.

 

c)
Lost or Mutilated Note. If this Note shall be mutilated, lost, stolen
or destroyed, Borrower shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated Note,
or in lieu of or in substitution for a lost, stolen or destroyed Note, a new Note for the principal amount of this Note so mutilated,
lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such Note, and of the ownership
hereof, reasonably satisfactory to Borrower.

 

d)
Governing Law. All questions concerning the construction, validity,
enforcement and interpretation of this Note shall be governed by and construed and enforced in accordance with the internal laws
of the State of New York, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings
concerning the interpretation, enforcement and defense of the transactions contemplated by the Note (whether brought against a
party hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state
and federal courts sitting in the City of New York, Borough of Manhattan (the “New York Courts”). Each party
hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such
New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably
waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy
thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all
right to trial by jury in any legal proceeding arising out of or relating to this Note or the transactions contemplated hereby.
Each party shall be responsible for its own legal fees and costs in the event any party shall commence an action or proceeding
to enforce any provisions of this Note.

 

e)
Waiver. Any waiver by Borrower or the Holder of a breach of any provision
of this Note shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any
other provision of this Note. The failure of Borrower or the Holder to insist upon strict adherence to any term of this Note on
one or more occasions shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence
to that term or any other term of this Note on any other occasion. Any waiver by Borrower or the Holder must be in writing.

 

f) Severability.
If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in effect, and if any
provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances.

 

g)
Usury. If it shall be found that any interest or other amount deemed interest
due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be
lowered to equal the maximum rate of interest permitted under applicable law.

 

h)
Next Business Day. Whenever any payment or other obligation hereunder shall be
due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

 

    8

     

    

 

i) Headings.
The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit
or affect any of the provisions hereof.

 

j) Amendment.
Unless otherwise provided for hereunder, this Note may not be modified or amended or the provisions hereof waived without the
written consent of Borrower and the Holder.

 

k) Facsimile
Signature. In the event that the Borrower’s signature is delivered by facsimile transmission, PDF, electronic
signature or other similar electronic means, such signature shall create a valid and binding obligation of the Borrower with
the same force and effect as if such signature page were an original thereof.

 

IN
WITNESS WHEREOF, Borrower has caused this Note to be signed in its name by an authorized officer as of the 29th
day of February, 2016.

 

	 	THERANOSTICS
    HEALTH, INC.
	 	 	 
	 	By:
    	 
	 	 	Name:
	 	 	Title:

 

    9

     

    

 

Exhibit
A

Investment
Representations for Accredited Investor 

 

The
Holder hereby acknowledges, agrees with and represents, warrants and covenants to the Borrower, as follows:

 

(a)Accredited
Investor. The Holder is an “accredited investor” as that term is defined in Regulation D promulgated under the
Securities Act by virtual of being (initial all applicable responses below):

 

	 	[__]	an
    individual (not a partnership, corporation, etc.) whose individual net worth, or joint net worth with his or her spouse, presently
    exceeds $1,000,000.  For purposes of calculating net worth under this paragraph, (i) the primary residence shall
    not be included as an asset, (ii) to the extent that the indebtedness that is secured by the primary residence is in excess
    of the fair market value of the primary residence, the excess amount shall be included as a liability, and (iii) if the amount
    of outstanding indebtedness that is secured by the primary residence exceeds the amount outstanding 60 days prior to the execution
    of this Subscription Agreement, other than as a result of the acquisition of the primary residence, the amount of such excess
    shall be included as a liability.
	 	[__]	an
    individual (not a partnership, corporation, etc.) who had an income in excess of $200,000 in each of the two most recent years,
    or joint income with his or her spouse in excess of $300,000 in each of those years (in each case including foreign income,
    tax exempt income and full amount of capital gains and losses but excluding any income of other family members and any unrealized
    capital appreciation) and has a reasonable expectation of reaching the same income level in the current year 
	 	[__]	a
    bank as defined in section 3(a)(2) of the Act, or a savings and loan association or other institution as defined in section
    3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity; a broker or dealer registered pursuant to section
    15 of the Securities Exchange Act of 1934; an insurance company as defined in section 2(a)(13) of the Act; an investment company
    registered under the Investment Company Act of 1940 or a business development company as defined in section 2(a)(48) of that
    Act; a Small Business Investment Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of
    the Small Business Investment Act of 1958; any plan established and maintained by a state, its political subdivisions, or
    any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has
    total assets in excess of $5,000,000; any employee benefit plan within the meaning of the Employee Retirement Income Security
    Act of 1974 if the investment decision is made by a plan fiduciary, as defined in section 3(21) of such act, which is either
    a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan
    has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that
    are accredited investors.
	 	[__]	a
    private business development company as defined in section 202(a)(22) of the Investment Advisors Act of 1940.
	 	[_X_]	a
    corporation, partnership, Massachusetts business trust, or nonprofit organization within the meaning of Section 501(c)(3)
    of the Internal Revenue Code, in each case not formed for the specific purpose of acquiring the securities being offered and
    with total assets in excess of $5,000,000.
	 	[__]	a
    trust with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Note, whose purchase
    is directed by a “sophisticated investor” as defined in Regulation 506(b)(2)(ii) under the Act.
	 	[__]	an
    entity in which all of the equity owners are “accredited investors” within one or more of the above categories.  

 

    10

     

    

 

(b)Experience.
The Holder is sufficiently experienced in financial and business matters to be capable of evaluating the merits and risks of its
investments, and to make an informed decision relating thereto, and to protect its own interests in connection with the purchase
of the Note.

 

(c)Own
Account. The Holder is purchasing the Note as principal for its own account, for investment purposes only and not with an
intent or view towards further sale or distribution (as such term is used in Section 2(11) of the Securities Act) thereof, and
has not pre-arranged any sale with any other person and has no plans to enter into any such agreement or arrangement.

 

(d)Exemption.
The Holder understands that the offer and sale of the Note is not being registered under the Securities Act or any state securities
laws and is intended to be exempt from registration provided by Rule 506 promulgated under Regulation D and/or Section 4(a)(2)
of the Securities Act;

 

(e)Importance
of Representations. The Holder understands that the Note are being offered and sold to it in reliance on an exemption from
the registration requirements of the Securities Act, and that the Borrower is relying upon the truth and accuracy of the representations,
warranties, agreements, acknowledgments and understandings of the Holder set forth herein in order to determine the applicability
of such safe harbor and the suitability of the Holder to acquire the Note;

 

(f)No
Registration. The Note have not been registered under the Securities Act or any state securities laws and may not be transferred,
sold, assigned, hypothecated or otherwise disposed of unless registered under the Securities Act and applicable state securities
laws or unless an exemption from such registration is available (including, without limitation, under Rule 144 of the Securities
Act, as such rule may be amended, or any similar rule or regulation hereafter adopted by the Commission having substantially the
same effect (“Rule 144”)). The Holder represents and warrants and hereby agrees that all offers and sales of the Note
and the Note shall be made only pursuant to such registration or to such exemption from registration.

 

(g)Risk.
The Holder acknowledges that the purchase of the Note involves a high degree of risk, is aware of the risks and further acknowledges
that it can bear the economic risk of the Note, including the total loss of its investment. The Holder has adequate means of providing
for its financial needs and foreseeable contingencies and has no need for liquidity of its investment in the Note for an indefinite
period of time.

 

(h)Borrower
Information. The Holder and its representatives have received all the documents requested by the Holder, have carefully reviewed
them and understand the information contained therein.

 

    11

     

    

 

(i)Independent
Investigation. The Holder, in making the decision to purchase the Note subscribed for, has relied upon independent investigations
made by it and its representatives, if any, and the Holder and such representatives, if any, have prior to any sale to it been
given access and the opportunity to examine all material contracts and documents relating to this investment and an opportunity
to ask questions of, and to receive answers from, the Borrower or any person acting on its behalf concerning the terms and conditions
of this investment. The Holder and its advisors, if any, have been furnished with access to all materials relating to the business,
finances and operation of the Borrower and materials relating to the offer and sale of the Note which have been requested. The
Holder and its advisors, if any, have received complete and satisfactory answers to any such inquiries.

 

(j)No
Recommendation or Endorsement. The Holder understands that no federal, state or other regulatory authority has passed on or
made any recommendation or endorsement of the Note. Any representation to the contrary is a criminal offense.

 

(k)No
Representation. In evaluating the suitability of an investment in the Borrower, the Holder has not relied upon any representation
or information (oral or written) other than as stated in the Note.

 

(l)No
Tax, Legal, Etc. Advice. The Holder is not relying on the Borrower or any of its employees or agents with respect to the legal,
tax, economic and related considerations of an investment in the Note, and the Holder has relied on the advice of, or has consulted
with, only its own advisers.

 

(m)No
Advertisement or General Solicitation. Holder acknowledges that it is not aware of, is in no way relying on, and did not become
aware of the offering of the Note through or as a result of any form of general solicitation or general advertising, including,
without limitation, any article, notice, advertisement or other communication published in any newspaper, magazine, or similar
media or broadcast over television or radio, or through any seminar or meeting whose attendees have been invited by any general
solicitation or general advertising.

 

	Amarantus Bioscience Holdings, Inc.	 
	 	 	 
	By:	 	 
	 	Gerald Commissiong, President & CEO	 

 

Address:
655 Montgomery Street

 

San
Francisco, CA 94111

 

Email
Address: gerald.commissiong@amarantus.com

 

Fax:
______________________________

 

Tax
ID: ____________________________

 

__________________________________

Date

 

 

12EX-10.1

 Exhibit 10.1 

TARGA RESOURCES CORP. 

INDEMNIFICATION AGREEMENT 

THIS AGREEMENT (the “Agreement”) is effective March 1, 2016, between Targa Resources Corp., a Delaware corporation (the
“Corporation”), and the undersigned individual who serves as a director or officer of the Corporation (“Indemnitee”). 

WHEREAS, the Corporation has adopted Bylaws (as the same may be amended from time to time, the “Bylaws”) providing for
indemnification of the Corporation’s directors and officers to the maximum extent authorized by the Delaware General Corporation Law (the “DGCL”); and 

WHEREAS, in recognition of Indemnitee’s need for substantial protection against personal liability in order to enhance Indemnitee’s
continued service to the Corporation in an effective manner, the Corporation wishes to provide in this Agreement for the indemnification of and the advancing of expenses to Indemnitee to the fullest extent permitted by law (whether partial or
complete) and as set forth in this Agreement, and, to the extent insurance is maintained, for the continued coverage of Indemnitee under the Corporation’s directors’ and officers’ liability insurance policies; 

WHEREAS, Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Corporation on condition
that the Indemnitee be so indemnified; 
 NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the
Corporation and Indemnitee do hereby covenant and agree as follows: 
  

	 	1.	Definitions. 

 As used in this Agreement: 

(a) The term “Proceeding” shall include any threatened, pending or completed action, suit, inquiry or proceeding, whether brought by
or in the right of the Corporation or any predecessor, subsidiary or affiliated company or otherwise and whether of a civil, criminal, administrative, arbitrative or investigative nature, in which Indemnitee is or will be involved as a party, as a
witness or otherwise, by reason of the fact that Indemnitee is or was a director or officer of the Corporation, by reason of any action taken by him or of any inaction on his part while acting as a director or officer or by reason of the fact that
he is or was serving at the request of the Corporation as a director, officer, trustee, employee or agent of another corporation, partnership, joint venture, trust, limited liability company or other enterprise; in each case whether or not he is
acting or serving in any such capacity at the time any liability or expense is incurred for which indemnification or reimbursement can be provided under this Agreement; provided that any such action, suit or proceeding which is brought by Indemnitee
against the Corporation or any predecessor, subsidiary or affiliated company or directors or officers of the Corporation or any predecessor, subsidiary or affiliated company, other than an action brought by Indemnitee to enforce his rights under
this Agreement, shall not be deemed a Proceeding without prior approval by a majority of the Board of Directors of the Corporation. 

 (b) The term “Expenses” shall include, without limitation, any judgments, fines and
penalties against Indemnitee in connection with a Proceeding; amounts paid by Indemnitee in settlement of a Proceeding; and all attorneys’ fees and disbursements, accountants’ fees, private investigation fees and disbursements, retainers,
court costs, transcript costs, fees of experts, fees and expenses of witnesses, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements, or expenses, reasonably
incurred by or for Indemnitee in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in a Proceeding or establishing Indemnitee’s right of entitlement to indemnification
for any of the foregoing. 
 (c) References to Indemnitee’s being or acting as “a director or officer of the Corporation” or
“serving at the request of the Corporation as a director, officer, trustee, employee or agent of another corporation, partnership, joint venture, trust, limited liability company or other enterprise” shall include in each case service to
or actions taken while a director, officer, trustee, employee or agent of any predecessor, subsidiary or affiliated company of the Corporation. 

(d) References to “other enterprise” shall include employee benefit plans; references to “fines” shall include any excise
tax assessed with respect to any employee benefit plan; references to “serving at the request of the Corporation” shall include any service as a director, officer, employee or agent of the Corporation which imposes duties on, or involves
services by, such director, officer, trustee, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he reasonably believed to be in the interests of the
participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interest of the Corporation” as referred to in this Agreement. 

(e) The term “substantiating documentation” shall mean copies of bills or invoices for costs incurred by or for Indemnitee, or
copies of court or agency orders or decrees or settlement agreements, as the case may be, accompanied by a statement from Indemnitee that such bills, invoices, court or agency orders or decrees or settlement agreements, represent costs or
liabilities meeting the definition of “Expenses” herein. 
 (f) The terms “he” and “his” have been used for
convenience and mean “she” and “her” if Indemnitee is a female. 
  

	 	2.	Indemnity of Director or Officer. 

 The Corporation hereby agrees (subject to the provisions of
Section 5 below) to hold harmless and indemnify Indemnitee against Expenses to the fullest extent authorized or permitted by law (including the applicable provisions of the DGCL). The phrase “to the fullest extent permitted by law”
shall include, but not be limited to (a) to the fullest extent permitted by any provision of the DGCL that authorizes or permits additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the
DGCL and (b) to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors. Any
amendment, alteration or repeal of the DGCL that adversely affects 

  
 2 

 
any right of Indemnitee shall be prospective only and shall not limit or eliminate any such right with respect to any Proceeding involving any occurrence or alleged occurrence of any action or
omission to act that took place prior to such amendment or repeal. 
  

	 	3.	Additional Indemnity. 

 The Corporation hereby further agrees (subject to the provisions of
Section 5 below) to hold harmless and indemnify Indemnitee against Expenses incurred by reason of the fact that Indemnitee is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the
Corporation as a director, officer, trustee, employee or agent of another corporation, partnership, joint venture, trust, limited liability company or other enterprise, including, without limitation, any predecessor, subsidiary or affiliated entity
of the Corporation, but only if Indemnitee acted in good faith and, in the case of conduct in his official capacity, in a manner he reasonably believed to be in the best interests of the Corporation and, in all other cases, not opposed to the best
interests of the Corporation. Additionally, in the case of a criminal proceeding, Indemnitee must have had no reasonable cause to believe that his conduct was unlawful. The termination of any Proceeding by judgment, order of the court, settlement,
conviction or upon a plea of nolo contendere, or its equivalent, shall not, of itself, create a presumption that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interest of the
Corporation, and with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his conduct was unlawful. 
  

	 	4.	Contribution. 

 If the indemnification provided under Section 2 is unavailable by reason of a court
decision, based on grounds other than any of those set forth in Section 5 below, then, in respect of any Proceeding in which the Corporation is jointly liable with Indemnitee (or would be if joined in such Proceeding), the Corporation shall
contribute to the amount of Expenses actually and reasonably incurred and paid or payable by Indemnitee in such proportion as is appropriate to reflect (i) the relative benefits received by the Corporation on one hand and Indemnitee on the
other from the transaction from which such Proceeding arose and (ii) the relative fault of the Corporation on the one hand and of Indemnitee on the other in connection with the events that resulted in such Expenses as well as any other relevant
equitable considerations. The relative fault of the Corporation on the one hand and of Indemnitee on the other shall be determined by reference to, among other things, the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent the circumstances resulting in such Expenses. The Corporation agrees that it would not be just and equitable if contribution pursuant to this Section 4 were determined by pro rata allocation or any other method
of allocation that does not take into account of the foregoing equitable considerations. 

  
 3 

	 	5.	Exceptions. 

 Any other provision herein to the contrary notwithstanding, the Corporation shall not be
obligated pursuant to the terms of this Agreement: 
 (a) Claims Initiated by Indemnitee. To indemnify or advance expenses to
Indemnitee with respect to proceedings or claims initiated or brought voluntarily by Indemnitee and not by way of defense, except with respect to proceedings brought to establish or enforce a right to indemnification under this Agreement; 

(b) Insured Claims. To indemnify Indemnitee for expenses or liabilities of any type whatsoever (including, but not limited to,
judgments, fines, ERISA excise taxes or penalties, and amounts paid in settlement) to the extent such expenses or liabilities have been paid directly to Indemnitee by an insurance carrier under a policy of officers’ and directors’
liability insurance; 
 (c) Claims Under Section 16(b). To indemnify Indemnitee for expenses or the payment of profits arising
from the purchase and sale by Indemnitee of securities in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute; 

(d) Unlawful Claims. To indemnify Indemnitee to the extent such indemnification is prohibited by applicable law; or 

(e) Unauthorized Settlement. To indemnify Indemnitee with regard to any judicial award if the Corporation was not given a reasonable
and timely opportunity, to participate in the defense of such action or to indemnify Indemnitee for any amounts paid in settlement of any Proceeding effected without the Corporation’s prior written consent. 

 

	 	6.	Choice of Counsel. 

 If Indemnitee is not an officer of the Corporation, he, together with the other
directors who are not officers of the Corporation and are seeking indemnification (the “Outside Directors”), shall be entitled to employ, and be reimbursed for the fees and disbursements of, a single counsel separate from that chosen by
Indemnitees who are officers of the Corporation. The principal counsel for Outside Directors (“Principal Counsel”) shall be determined by majority vote of the Outside Directors who are seeking indemnification, and the Principal Counsel for
the Indemnitees who are not Outside Directors (“Separate Counsel”) shall be determined by majority vote of such Indemnitees, in each case subject to the consent of the Corporation (not to be unreasonably withheld or delayed). The
obligation of the Corporation to reimburse Indemnitee for the fees and disbursements of counsel hereunder shall not extend to the fees and disbursements of any counsel employed by Indemnitee other than Principal Counsel or Separate Counsel, as the
case may be, unless Indemnitee has interests that are different from those of the other Indemnitees or defenses available to him that are in addition to or different from those of the other Indemnitees such that Principal Counsel or Separate
Counsel, as the case may be, would have an actual or potential conflict of interest in representing Indemnitee. 
  

	 	7.	Advances of Expenses. 

 (a) Expenses (other than judgments, penalties, fines and
settlements) incurred by Indemnitee shall be paid by the Corporation, in advance of the final disposition of the Proceeding, within three business days after receipt of Indemnitee’s written request accompanied

  
 4 

 
by substantiating documentation and Indemnitee’s written affirmation as described in subsection (c) below. No objections based on or involving the question whether such charges meet the
definition of “Expenses,” including any question regarding the reasonableness of such Expenses, shall be grounds for failure to advance to such Indemnitee, or to reimburse such Indemnitee for, the amount claimed within such three business
day period, and the undertaking of Indemnitee set forth in this Section 7 to repay any such amount to the extent it is ultimately determined that Indemnitee is not entitled to indemnification shall be deemed to include an undertaking to repay
any such amounts determined not to have met such definition. 
 (b) Indemnitee hereby undertakes to repay to the Corporation (i) any
advances or payment of Expenses made pursuant to this Section 7 and (ii) any judgments, penalties, fines and settlements paid to or on behalf of Indemnitee hereunder, in each case to the extent that it is ultimately determined in a final
judgment or other final adjudication of a court of competent jurisdiction that Indemnitee is not entitled to indemnification. 
 (c) As a
condition to the advancement of such Expenses or the payment of such judgments, penalties, fines and settlements, Indemnitee shall execute an acknowledgment wherein Indemnitee (i) affirms that Indemnitee has met the standard of conduct for
indemnification and (ii) affirms that such Expenses or such judgments, penalties, fines and settlements, as the case may be, are delivered pursuant and are subject to the provisions of this Agreement. 

 

	 	8.	Right of Indemnitee to Indemnification Upon Application; Procedure Upon Application. 

 Any
indemnification claim under this Agreement, other than pursuant to Section 7 hereof, shall be made no later than 30 days after receipt by the Corporation of the written request of Indemnitee, accompanied by substantiating documentation, unless
a determination is made within said 30-day period that Indemnitee has not met the relevant standards for indemnification set forth in Section 3 hereof by (a) the Board of Directors by a majority vote of a quorum consisting of directors who
are not or were not parties to such Proceeding, (b) a committee of the Board of Directors designated by majority vote of the Board of Directors, even though less than a quorum, (c) if there are no such directors, or if such directors so
direct, independent legal counsel in a written opinion or (d) the stockholders. 
 The right to indemnification or advances as provided
by this Agreement shall be enforceable by Indemnitee in any court of competent jurisdiction. The burden of proving that indemnification is not appropriate shall be on the Corporation. Neither the failure of the Corporation (including its Board of
Directors, any committee thereof, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such action that indemnification is proper in the circumstances because Indemnitee has met the applicable
standards of conduct, nor an actual determination by the Corporation (including its Board of Directors, any committee thereof, independent legal counsel or its stockholders) that Indemnitee has not met such applicable standard of conduct, shall be a
defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct. 

  
 5 

	 	9.	Indemnification Hereunder Not Exclusive. 

 The indemnification and advancement of expenses provided by
this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may be entitled under the Corporation’s charter or certificate of incorporation (as the same may be amended from time to time), the Bylaws, the DGCL, any
directors and officers insurance maintained by or on behalf of the Corporation, any agreement, or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office; provided, however, that this
Agreement supersedes all prior written indemnification agreements between the Corporation (or any predecessor thereof) and Indemnitee with respect to the subject matter hereof. However, Indemnitee shall reimburse the Corporation for amounts paid to
Indemnitee pursuant to such other rights to the extent such payments duplicate any payments received pursuant to this Agreement. 
  

	 	10.	Continuation of Indemnity. 

 All agreements and obligations of the Corporation contained herein shall
continue during the period Indemnitee is a director or officer of the Corporation (or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, limited
liability company or other enterprise) and shall continue thereafter so long as Indemnitee shall be subject to any possible Proceeding (notwithstanding the fact that Indemnitee has ceased to serve the Corporation). 

 

	 	11.	Partial Indemnification. 

 If Indemnitee is entitled under any provision of this Agreement to
indemnification by the Corporation for a portion of Expenses, but not, however, for the total amount thereof, the Corporation shall nevertheless indemnify Indemnitee for the portion of such Expenses to which Indemnitee is entitled. 

 

	 	12.	Acknowledgements. 

 The Corporation expressly confirms and agrees that it has entered into this Agreement
and assumed the obligations imposed on the Corporation hereby in order to induce Indemnitee to serve or to continue to serve as a director or officer of the Corporation, and acknowledges that Indemnitee is relying upon this Agreement in agreeing to
serve or in continuing to serve as a director or officer of the Corporation. 
  

	 	13.	Enforcement. 

 In the event Indemnitee is required to bring any action or other proceeding to enforce
rights or to collect moneys due under this Agreement and is successful in such action, the Corporation shall reimburse Indemnitee for all of Indemnitee’s expenses in bringing and pursuing such action. 

 

	 	14.	Severability. 

 If any provision of this Agreement shall be held to be invalid, illegal or unenforceable
(a) the validity, legality and enforceability of the remaining provisions of this Agreement shall not be in any way affected or impaired thereby, and (b) to the fullest extent possible, the provisions of this

  
 6 

 
Agreement shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable. Each section of this Agreement is a separate and independent
portion of this Agreement. If the indemnification to which Indemnitee is entitled with respect to any aspect of any claim varies between two or more sections of this Agreement, that section providing the most comprehensive indemnification shall
apply. 
  

	 	15.	Liability Insurance. 

 To the extent the Corporation maintains an insurance policy or policies providing
directors’ and officers’ liability insurance, Indemnitee shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available and maintained by the Corporation for any director
or officer of the Corporation or any applicable subsidiary or affiliated company. 
  

	 	16.	Miscellaneous. 

 (a) Governing Law. This Agreement and all acts and transactions
pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflict of law. 

(b) Entire Agreement; Enforcement of Rights. This Agreement sets forth the entire agreement and understanding of the parties relating
to the subject matter herein and merges all prior discussions between them. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to this
Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party. 

(c) Construction. This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and their
respective counsel, if any; accordingly, this Agreement shall be deemed to be the product of all of the parties hereto, and no ambiguity shall be construed in favor of or against any one of the parties hereto. 

(d) Notices. All notices, demands or other communications to be given or delivered under or by reason of the provisions of this
Agreement shall be in writing and shall be deemed to have been given (i) when delivered personally to the recipient, (ii) one business day after the date when sent to the recipient by reputable overnight courier service (charges prepaid),
or (iii) five business days after the date when mailed to the recipient by certified or registered mail, return receipt requested and postage prepaid. Such notices, demands and other communications shall be sent to the parties at the addresses
indicated on the signature page hereto, or to such other address as any party hereto may, from time to time, designate in writing delivered pursuant to the terms of this Section 16(d). 

(e) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of
which together shall constitute one instrument. 

  
 7 

 (f) Successors and Assigns. This Agreement shall be binding upon the Corporation and its
successors and assigns and shall inure to the benefit of Indemnitee and Indemnitee’s heirs, legal representatives and assigns. 
 (g)
Subrogation. In the event of payment under this Agreement, the Corporation shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all documents required and shall do all acts that
may be necessary to secure such rights and to enable the Corporation to effectively bring suit to enforce such rights. 

  
 8 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the day and year
first above written. 
  

			
	TARGA RESOURCES CORP.
		
	By:	 	 /s/ Joe Bob Perkins

	Name:	 	Joe Bob Perkins
	Title:	 	Chief Executive Officer

 
			
		
	Address:	 	1000 Louisiana, Suite 4300
		 	Houston, Texas 77002
	
	INDEMNITEE:
	
	 /s/ Robert B. Evans

	Robert B. Evans
		
	Address:	 	100 College St.
		 	Minden, Louisiana 71055

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]